Hikma Pharmaceuticals Share Price (HIK)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Hikma Pharmaceuticals Plc	LSE:HIK	London	Ordinary Share	GB00B0LCW083	ORD SHS 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-38.00	-1.7%	2,199.00	177,719	15:56:16

Bid Price		Offer Price	High Price	Low Price	Open Price
2,198.00		2,200.00	2,237.00	2,191.00	2,222.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	1,712.25	408.13	133.56	16.7	5,069

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
15:56:21	O	227	2,198.745	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Motif Bio (MTFB), Bermele (BERM)

Hikma Pharmaceuticals (HIK) Latest News

Hikma Pharmaceuticals News

Date	Time	Source	Headline
02/3/2021	17:50	ALNC	IN BRIEF: Hikma Pharmaceuticals non-exec director buys 1,500 shares
02/3/2021	16:44	UKREG	Hikma Pharmaceuticals Plc Director/PDMR Shareholding
25/2/2021	13:02	UKREG	Hikma Pharmaceuticals Plc Director/PDMR Shareholding
25/2/2021	13:01	UKREG	Hikma Pharmaceuticals Plc Director/PDMR Shareholding
25/2/2021	13:00	UKREG	Hikma Pharmaceuticals Plc Director/PDMR Shareholding
25/2/2021	08:38	ALNC	TOP NEWS: Hikma Hikes Dividend Amid Growth From All Three Businesses
25/2/2021	07:00	UKREG	Hikma Pharmaceuticals Plc Final Results
08/2/2021	14:55	UKREG	Hikma Pharmaceuticals Plc Notice of Results
26/1/2021	08:45	DJN	Hikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some..
26/1/2021	08:28	ALNC	TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

More Hikma Pharmaceuticals News

Hikma Pharmaceuticals Investors Hikma Pharmaceuticals Takeover Rumours

Hikma Pharmaceuticals (HIK) Share Charts 1 Year Hikma Pharmaceuticals Chart
1 Month Hikma Pharmaceuticals Chart	Intraday Hikma Pharmaceuticals Chart

Hikma Pharmaceuticals (HIK) Discussions and Chat

Hikma Pharmaceuticals Forums and Chat

Date	Time	Title	Posts
04/3/2021	14:15	Hikma Pharmaceuticals	1,165
13/1/2015	15:12	* Hikma *	98

Add a New Thread

Hikma Pharmaceuticals (HIK) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
15:56:22	2,198.75	227	4,991.15	O
15:56:15	2,199.00	20	439.80	AT
15:56:13	2,199.00	77	1,693.23	AT
15:56:13	2,199.00	71	1,561.29	AT
15:56:13	2,199.00	114	2,506.86	AT

View all Hikma Pharmaceuticals trades in real-time

Hikma Pharmaceuticals (HIK) Top Chat Posts

Date	Subject
05/3/2021 08:20	Hikma Pharmaceuticals Daily Update: Hikma Pharmaceuticals Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 2,237p. Hikma Pharmaceuticals Plc has a 4 week average price of 2,191p and a 12 week average price of 2,191p. The 1 year high share price is 2,766p while the 1 year low share price is currently 1,596p. There are currently 230,495,233 shares in issue and the average daily traded volume is 833,970 shares. The market capitalisation of Hikma Pharmaceuticals Plc is £5,061,675,316.68. Read Full Thread Reply
26/12/2020 23:22	thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days before Xmas and part of our discussion includes HIK which I know C3 is keen on. We also chatted about loads of other Stocks and Ideas for research. We discussed the outlook for Markets and the most likely roadmap for the next couple of months, and as usual a fair bit of educational stuff with regards to Investing. Anyway, if you use Youtube, Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 38) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !! Season’s Greetings !! WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-38-takeovers-vla-azn-pfe-bntx-alxn-gsk-cdm-hik-vec-av-futr Read Full Thread Follow Reply
24/12/2020 07:52	johnrxx99: I'd go for the cheapest whatever, as long as it's from a recognised producer. The price never remains the same. Read Full Thread Follow Reply
23/12/2020 11:58	montyhedge: Of course but what you prefer the original for the same price has a generic version. The pie big enough for everyone, GSK not going to let companies eat their lunch. Read Full Thread Follow Reply
21/12/2020 11:55	montyhedge: I like Hik. All I'm saying the pie in Advair seems to me will be small for everyone, if undercutting goes on. Read Full Thread Follow Reply
21/12/2020 09:45	suetballs: Well monty buy some hik to hedge your bets. I own both shares. Suet Read Full Thread Follow Reply
18/12/2020 19:54	scepticalinvestor: its the same thing monty.gsk will have to cut their price by 70% to compete... Read Full Thread Follow Reply
18/12/2020 16:48	montyhedge: Let's see for 2021, GSK will fight back. The genuine article for the same price or generic version. I know what I would buy. Read Full Thread Follow Reply
18/12/2020 15:53	polaris: Montyhedge - are you serious? Mylan (now Viatris) launched a generic Advair in January 2019. The total GSK sales of Advair in the US are less than half of what they were in late 2018. Mylan aggressively price cut and took significant market share. The Hikma/VEC product will just exacerbate this margin cut. If you are going to make a comment, at least look at the market before punting BS. edit I'll lay it out for you, nice and simple. GSK US Advair sales: 2017 £1.61 Bn 2018 £1.097 Bn 2019 £502 M 2020 ytd £361 M GSK reduced prices in 2018, and switched patients to other products, getting ready for the generic entry. Spot the fall in sales... Read Full Thread Follow Reply
18/12/2020 15:47	montyhedge: GSK will lower their price surely and blow Hikma out the water. The real thing or a generic version for the same price. Let the battle begin in 2021. Read Full Thread Follow Reply
18/12/2020 08:24	robertball: I thought HIK would jump a bit higher. I guess it's got it's momentum back now. Read Full Thread Follow Reply

Hikma Pharmaceuticals share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

HIK

Hikma Phar..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20210305 16:11:26